Loading...

BeOne Medicines Ltd.

ONCNASDAQ
Healthcare
Medical - Pharmaceuticals
$291.47
$-4.99(-1.68%)

BeOne Medicines Ltd. (ONC) Stock Competitors & Peer Comparison

See (ONC) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ONC$291.47-1.68%33.2B-80.29-$3.63N/A
INSM$103.95+0.42%19.7B-17.53-$5.93N/A
WBA$11.61+0.17%10B-1.59-$7.29+4.30%
HROWL$25.45+0.86%1.4BN/AN/AN/A
HROWM$26.28-0.06%1.4BN/AN/A+11.35%
LFMDP$24.02+0.61%1.1B-10.64-$2.26N/A
LFMD$10.69+0.19%485.8M-32.39-$0.33N/A
HITI$2.31-2.53%187.2M-25.67-$0.09N/A
PETS$3.77-5.28%77.9M377.00$0.01N/A
YI$7.32-0.81%63.4M-3.37-$2.17N/A
Showing 1 to 10 of 21 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ONC vs INSM Comparison July 2025

ONC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ONC stands at 33.2B. In comparison, INSM has a market cap of 19.7B. Regarding current trading prices, ONC is priced at $291.47, while INSM trades at $103.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ONC currently has a P/E ratio of -80.29, whereas INSM's P/E ratio is -17.53. In terms of profitability, ONC's ROE is -0.12%, compared to INSM's ROE of -4.47%. Regarding short-term risk, ONC is more volatile compared to INSM. This indicates potentially higher risk in terms of short-term price fluctuations for ONC.Check INSM's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;